Introducing Upneeq



Droopy Eyelids in Adults

Many Americans suffer from a condition called blepharoptosis, also known as droopy eyelids syndrome. According to research, this condition is more commonly affecting adults over the age of 50 but may affect any individual. Blepharoptosis can affect one or both eyelids and can be present at birth or acquired over time. There are several causes of blepharoptosis: congential, paralysis of 1 of 2 eyelid muscles over time, or trauma in or around the eye.

Non-Invasive FDA Approved Solution: UPNEEQ

Upneeq is a simple eye drop can help the patient’s droopy eye lids open up within minutes and can last up to 6-8 hours without the need for invasive surgery. The upper eyelid normally covers 1-2mm of the upper cornea, but blepharoptosis can cause the eyelid to droop greater than 2mm, which could lead to loss of vision if severe enough. The most common symptom for droopy eyelids are the development of wrinkles on the forehead. This occurs to do an involuntary attempt in lifting the eyelid by the body to compensation the droopiness.

Until now, the only treatment for blepharoptosis was medically necessary surgery, which was reserved for only the most severe cases. Without some sort of vision loss, the surgery would be considered cosmetic and therefore, not covered by insurance. Fortunately, there is a new non-surgical option thanks to Upneeq. Upneeq is the first and only ophthalmic formulation approved by the U.S. Food and Drug Administration (FDA) for the treatment of acquired blepharoptosis or ptosis (droopy eyelids) in adults.

In the end, this once daily eyedrop will lift your droopy eyelids, improve your field of vision, make you appear refreshed and alert. Click below to learn more or schedule your Upneeq Consultation TODAY!


Tags: , , , , , , , , , ,